ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PHC Plant Health Care Plc

3.73
-0.02 (-0.53%)
23 Feb 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -0.53% 3.73 3.60 3.86 - 3,251 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -1.35 12.81M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.75p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 12.00p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £12.81 million. Plant Health Care has a price to earnings ratio (PE ratio) of -1.35.

Plant Health Care Share Discussion Threads

Showing 1276 to 1300 of 1350 messages
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
DateSubjectAuthorDiscuss
27/9/2023
16:04
i liked presentation a lot. they are spread around - northern and southern hemisphere. so seasonality reduced. no payment problems. professional production. RD fundament done. no problems getting registrations. best buyers/distributors. also - i could not think of a relevant question /due to my lack of knowledge/. i like PHC

i also expect that world food issues will tighten - so the focus on food related stocks will grow /general valuation increase/

kaos3
27/9/2023
15:48
I was interested in the emphasis in the IMC meeting about how tough
PHC's competitors/counterparts had found conditions in H1.
I do not know the US players but did check in with the Croda interims
and they do agree with what PHYC says-no idea where Croad's sales are made
quote
Following an exceptional 2022, when Crop Protection delivered both strong double-digit percentage volume growth and
price/mix, the business started the year with good momentum, delivering positive volumes and flat pricing in the first quarter
on a sequential basis. It began to experience rapid customer destocking in the second quarter, which was a factor originally
expected to materialise more gradually later in the year, with volumes down more than 30% compared with Q1. Overall, the
business grew sales in the half, with price increases and a favourable foreign exchange rate more than offsetting negative
volume.
In the Seed Enhancement business, which is approximately one third of the size of Crop Protection, a significant proportion
of sales are derived from providing enhancement services for vegetable seeds. As such, the business only sees a limited
impact from stocking cycles and delivered an 18% sales increase in the first half year, driven by strong structural growth
trends.
unquote

cerrito
27/9/2023
15:46
Still confident on the $30 million 2025 target and $10 million for the second half.Nothing changed but it's a bumpy road.Looking at that 1.5 million sale at the close somebody is not convinced.
geraldus
27/9/2023
14:29
The mid West drought rather passed me by but a Google search has sheen it was and is a big issue.
cerrito
27/9/2023
12:25
Sales to farmers in the US are up, seems the big distributors are clearing stocks and delaying purchases till H2.
That’s the problem with H1 H2 results, sometimes they don’t reflect the full year picture.

Looking forward the Europe picking up next year, especially Spain, Portugal, France and Poland.

pretax2
27/9/2023
09:04
Well,just had a top up.I'll tune in at 4pm see what's afoot.Gla.
geraldus
27/9/2023
08:29
I thought H1 would be a challenge coming after such a good 2022 FY. It can take a while to generate sales off the back of regulatory approvals. Beyond this, the US is preparing for a recession.
Thank goodness we are a global outfit; will help to smooth macro bumps.

pretax2
27/9/2023
07:37
Cavendish is house broker -
pugugly
27/9/2023
07:21
Cavendish still on a target of 44p.At the time of the June fundraise they said 'trading in the first half of 2023 has been strong with revenue meeting the expectations of management'.Let's hope they get the second half rebound,after all it is nearly October.Some great numbers going forward if they can achieve them.
geraldus
27/9/2023
07:16
Us sales disappointing, this will be a case of “show me the money”
davemac3
26/9/2023
11:38
it's almost as if they are preparing the market for a downbeat TS tomorrow yet the TS with the fundraising on 22nd June (just 8 days before the end of the period) stated "The Directors believe that the current outlook remains positive and prospects for 2023 are in line with market expectations for the full year. Trading in the first half of 2023 has been strong, with revenues meeting the expectations of management"

The only difference is that on 22nd June they said the $30m target was firmly on track whereas yesterday the word firmly was removed. Maybe reading too much into it!

callumross
26/9/2023
10:02
I have to say I was not impressed by referencing twice the usd30m revenue target for 2025 twice in the RNS of yesterday and it seemed a bit desperate especially as any Mexican authorization will not move the dial in 2025.
All will be revealed tomorrow

cerrito
26/9/2023
09:06
There is an Investor Meets presentation at 4pm tomorrow which you can sign up to and no doubt you can obtain clarification on what criteria the $30m is based on.
callumross
25/9/2023
14:17
If you read today’s announcement, the management say they are on track but only if they get regulatory approval in Mexico. The question is how many mote approvals are needed. This is as far as I am aware, that they have added this caveat. So I am not a happy monkey as I think that the early projected $30m was misleading. That said, if they do generate that figure the shares look exceedingly cheap.
sidam
25/9/2023
13:58
results on Wednesday, let's see if they are on track for $30m in 2025
davemac3
18/8/2023
08:42
Good news. I was surprised by the relatively small size of the market, although as they have been selling Harpin to the sugar sector for some time, their distribution channels are set up to hit the ground running though no idea of at what part of the crop cycle they would've sold.
Augurs well for a quick federal approval of PHC68949 which serves a very much bigger market

cerrito
18/8/2023
06:36
RNS
Great news from Brazil will move the revenue needle. Great opportunity to buy at the current shareprice.
Roll on the interims.

pretax2
01/8/2023
15:24
If Cenkos estimates are correct, in less than six months the company will be profitable in the then current year. My experience suggests that, when companies are reporting initial profits, it is often a really good time to buy.

I hope I am right as I have a decent sized unit in this company.

sidam
01/8/2023
08:34
It seems that they need to get approval for Harpin on a country by country basis in the EU, despite the invoking of the term Mutual Recognition.
They mention potatoes which is a Harpin product.
Be good to find out in the next IMC session plans for 279 and 949 in Europe.
Yes I noticed in the last 3 years we had a TS by now and reminded myself that there was no AGM TS. Perhaps they aim to get the interims out earlier than the normal mid to late September.

cerrito
01/8/2023
06:47
Poland breakthrough. …
Interesting how it’s ProAct, an older product, that’s leading the charge for PHC. Just shows how long it takes to gain the regulatory approvals that we are now establishing after years of research. These are hurdles that many of our competitors have yet to cross. It also highlights the growth potential at PHC with the PreTEC products just starting to show traction.
Go PHC!

pretax2
29/7/2023
06:49
Lots of reasons. A delay in auditing or retrieving info (PHC is global and complex). Not a concern atm
pretax2
28/7/2023
13:23
Bit late with the post close trading update this year.
callumross
27/6/2023
08:50
Early trades are buys showing as sells.
Well done if you got in at the placing price yesterday.
Weird to see the share price the same as Jan 2022. Like the company has made no progress since then….?! Mr AIM Market very depressed and irrational.

pretax2
27/6/2023
06:41
Over 8 million sale yesterday below 9p.Who was that and anymore to come.Tin hat time?
geraldus
23/6/2023
06:41
Note that Cenkos have increased target price to 44p and say that the ROI is 25pc.
Just as well that they did it when the cable has risen to 1.27,obviously weak by historical standards but at least strong in the context of the last 12 months.
Good that Ospraie went in even if not as energetically as Scobie Ward. Note that Mr Griffiths passed... No idea of that is because he is nursing his losses on WAND and IQE.
Interesting coincidence on which I can draw no conclusions is that the RNS I got just before the PHC one this morning was from another AG Tech holding ANP who announced the result of a tender offer returning the cash to shareholders.

cerrito
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com